Lung Cancer, Natural Protocol, Felt Great, Started Playing Golf 2-3 Times a Week, Full of Energy


Lung Cancer, Natural Protocol, felt great, started playing golf 2-3 times a week, full of energy – Instructions on Protocol: Visit Lung Cancer Natural Approach Example Tony, Lung Cancer, 4 – 5 cm, he was feeling fine after a short while, which surprised his doctors. He started playing golf 2-3 times a week, which he had not done even before the cancer. About a year later, Tony was feeling great but decided to stop this program and went to do hyperthermia treatments and declined rapidly after those treatments and passed away. Other patients have had great results and if they stick with the program faithfully, we report great success stories. Visit to find more testimonials and learn more about the program. This protocol has also shown to help with alleviation of symptoms of ADHD, Allergies, Aneurysm, Anxiety, Arthritis, Asthma, Autism, Back & Joint Pain, Bells Palsy, Bi-Polar, Brain Damage, Bursitis, Candida Yeast, Cerebral Palsy, Chemical Poisoning, Cholesterol, Chronic Fatigue, Colds and Flu, Cyst & Fibroids, Diabetes, Diverticulosis, Down’s Syndrome, Drug Addiction, Eczema, Endurance, Epstein Barre, Fibroids, Fibromyalgia, Fungus – Nail, Toe etc., Glaucoma, Gout, Grave’s Disease, Guillian Barre, Headaches, Hearing Loss, Heart Conditions, Hemorrhoids, Hepatitis C, Hormone Imbalance, Huntington’s Disease, Hypertension, Inflammation, Injuries, Irritable Bowel, Joint Pain, Kidney Stones, Leg Cramps, Lung Disease, Lung Nodules, Lupus, Lymes, Manic Depression, Mental Clarity, Multiple Conditions, Multiple Sclerosis, Nail


Aeterna Zentaris: Late-Stage Drug Development Company With An Enterprise

Filed under: drug treatment news articles

The company has multiple catalysts coming up in the balance of 2012 and the beginning of 2013 but the key catalyst to watch is the Phase 3 data for Perifosine for the treatment of multiple myeloma, which is expected to come out in Q1 2013. … In a …
Read more on Seeking Alpha


PropThink: Esbriet Sales Demonstrating Growth; Expansion into New Markets

Filed under: drug treatment news articles

The drug already has Orphan Drug and Fast Track status domestically, suggesting that the FDA recognizes the need for an IPF treatment, and analysts lean towards a likely approval. … PropThink was not compensated to publish this article. Our full …
Read more on Reuters